Key takeaway
In 294 community-dwelling adults aged 65 and over, the Short Physical Performance Battery (SPPB) had moderate accuracy for sarcopenia (AUC 0.644 to 0.770), and a cut-point of 8 points or less caught 82-100% of severe cases but had only 36-41% specificity. Sarcopenia was rare (4 to 16%), so many people flagged would not have it.
Study design
Cross-sectional study
Reading basis
Published abstract
Reading focus
Association & confounding
The research question
Sarcopenia, the age-related loss of muscle mass, strength and function, is rarely diagnosed in clinics because the diagnostic process is labor-intensive. The SPPB is a quick, objective test of strength and physical performance, so the authors checked how well it identifies sarcopenia, alone and combined with lean mass.
Who and how
Cross-sectional analysis of 294 community-dwelling older persons (65 years and over). Appendicular lean body mass divided by height squared (ALM/h²), muscle strength (handgrip and sit-to-stand) and physical performance (gait speed, timed up and go, and SPPB) were measured with validated procedures. Sarcopenia was diagnosed using both the EWGSOP1 and EWGSOP2 criteria. Diagnostic ability of the SPPB, alone and combined with ALM/h², was judged by area under the curve (AUC), with candidate cut-points and their sensitivity and specificity.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Sarcopenia prevalence ranged from 4 to 16% depending on the definition used.
- 2The SPPB had moderate value for diagnosing sarcopenia, with AUC between 0.644 and 0.770.
- 3A cut-point of 8 points or less gave high sensitivity (82-100%) but low specificity (36-41%) for severe sarcopenia.
- 4The authors conclude the SPPB has acceptable value for severe sarcopenia and could be a screening tool where lean mass measurement is not available.
Limits & uncertainty
- 1Only 294 people were studied at one point in time, and severe sarcopenia was uncommon, so the sensitivity estimates rest on few cases.
- 2Low specificity (36-41%) means many people without severe sarcopenia would also test positive, so it works as a screen, not a diagnosis.
- 3Results depend on which definition (EWGSOP1 or EWGSOP2) is used, so they cannot be applied uniformly.
- 4This reading is based on the abstract only, which gives no confidence intervals for the AUCs or cut-point results.
What to take from it
A short chair-rise, walking and balance test is a reasonable first step to flag older adults who may need further assessment for sarcopenia, but a score of 8 or lower does not by itself mean someone has it. Anyone concerned about muscle weakness should have it assessed by a clinician.
Reading your own data
You can approximate parts of this at home, such as timing how long it takes to stand up from a chair repeatedly or tracking usual walking speed on a device. These are not the formal test, so use them only to compare yourself with your own earlier results under the same conditions, not as a diagnosis.
How to read this evidence
Measurements are taken in the same period. Direction and causation usually cannot be determined; symptoms can change behaviour as well as the reverse.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
Sarcopenia is defined as the age-related loss of muscle mass, strength, and physical performance. The original European Working Group on Sarcopenia in Older Persons (EWGSOP1) definition, and its revision (EWGSOP2), provide new cut-points and alternate measures for sarcopenia diagnosis. However, sarcopenia is rarely diagnosed in clinical settings owing to its labor-intensive diagnostic process. Given the Short Physical Performance Battery (SPPB) is a quick, easily administrable, and objective measure of muscle strength and physical performance, both of which are key components of sarcopenia, this study examined the diagnostic value of the SPPB for this muscle disease.
Methods
A cross-sectional analysis of 294 community-dwelling older persons (≥65 years) was conducted. Appendicular lean body mass [(ALM) divided by height squared (ALM/h^(2))], muscle strength (handgrip/sit to stand), and physical performance [gait speed, timed up and go (TUG) and SPPB] were assessed using validated procedures, while participants were diagnosed with sarcopenia following the EWGSOP1 and EWGSOP2 criteria. Diagnostic ability of the SPPB independently and combined with ALM/h^(2) for sarcopenia was determined using area under the curve (AUC). Potential cut-points were identified, and sensitivity and specificity calculated.
Results
Prevalence of sarcopenia ranged from 4 to 16% depending on the definition. The SPPB demonstrated moderate (AUC = 0.644-0.770) value in diagnosing sarcopenia, and a cut-point of ≤8points in SPPB performance resulted in high sensitivity (82-100%) but low specificity (36-41%) for diagnosing those with severe sarcopenia.
Conclusions
The SPPB displayed acceptable value in diagnosing older adults with severe sarcopenia. Moreover, the high sensitivity of the SPPB when using the cut-point of ≤8 suggests it may be a favorable screening tool for sarcopenia in clinical settings where ALM measurements are not available.
Sources & attribution
The diagnostic value of the Short Physical Performance Battery for sarcopenia.
Phu S, Kirk B, Bani Hassan E, Vogrin S, Zanker J, Bernardo S, Duque G.
BMC geriatrics · 2020-07-13
DOI: 10.1186/s12877-020-01642-4 ↗PubMed · 32660438 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

